Hoxworth Blood Center competitors

Michael Parejko is a Chief Executive Officer - Mississippi Valley Regional Blood Center at Mississippi Valley Regional Blood Center and is based in Davenport, Iowa. He has worked as COO/ EVP Indiana Blood Center at Indiana Blood Center, Medical Technologist at Northwestern Memorial Hospital, and Director of US Sales- Eastern Region at Pall Corporation. Michael works or has worked as Board Member at United Way of the Quad Cities Area. He studied at Indiana Wesleyan University between 2005 and 2007 and NMU between 1983 and 1988.

John Armitage is a CEO at Oklahoma Blood Institute, President at Global Blood Fund, and Manager at ALLIANCE FOR COMMUNITY TRANSFUSION SERVICES LLC and is based in London, Oklahoma City, Oklahoma. He has worked as Exec Director at New Jersey Blood Services, CEO and Medical Director at Appalachian Region - Am Red Cross, and CEO at Greater Alleghenies Region - Am Red Cross. John studied at Duke University School of Medicine, Yale, and North Carolina School of Science & Mathematics.

Christopher D. Hillyer, MD, President and CEO and Chief Scientific Officer of New York Blood Center (NYBC), and Professor, Department of Medicine, Weill Cornell Medical College, was previously the endowed Distinguished Service Professor, Department of Pathology and Laboratory Medicine, Emory University School of Medicine, where he served as director of the Emory Center for Transfusion and Cellular Therapies. He is board certified in transfusion medicine, hematology, medical oncology and internal medicine. He is an editor of 12 textbooks including the 16-18th editions of the AABB Technical Manual, and is recognized internationally as an expert in hematology, blood transfusion, and cellular therapies. His book, Transfusion Medicine and Hemostasis: Clinical and Laboratory Aspects, has become a primary resource throughout the world. Dr. Hillyer has authored more than 175 articles pertaining to transfusion, stem cells, erythropoiesis, and virology, and has been awarded millions of dollars in research funding from the National Institutes of Health, the CDC, and other agencies. He is a past-president of AABB, a former trustee of the National Blood Foundation, and served as an associate editor of TRANSFUSION.He is the 2014 Emily Cooley Award recipient for his “significant commitment and contributions to the field of transfusion medicine..." and was recognized with two Tiffany Awards from the American Red Cross for his work in Africa. Dr. Hillyer is an architect of NYBC Ventures, co-founder of Transfusion & Transplantation Technologies, Inc. (3Ti), HemeXcel Purchasing Alliance, and HemeXcel Resources, and holds a number of patents related to blood banking and cellular therapies. He has served on a number of for-profit and not-for-profit boards.Dr. Hillyer received his BS from Trinity College with Honors and his MD from the University of Rochester School of Medicine, with postgraduate fellowships in hematology-oncology, transfusion medicine and bone marrow transplantation at Tufts-New England Medical Center in Boston.

Scott Bush is a Chief Executive Officer at Suncoast Communities Blood Bank and is based in Sarasota, Florida. He has worked as Director of Donor Service and Recruitment at Suncoast Communities Blood Bank, Component Laboratory Supervisor at American Red Cross, and Laboratory/ Apheresis Manager: Western Lake Erie Region at American Red Cross. Scott studied at Columbus State Community College between 1989 and 1991, Ohio Dominican University between 1992 and 1995, and University of Central Florida - UCF Catering between 2010 and 2013.

Chad Douglas is a Chief Executive Officer at LIFESHARE BLOOD CENTERS. He has worked as Executive Director:Blood Ops at Lifesource Blood Services. Chad works or has worked at United States Air Force. He studied at University of Central Florida.